Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Xinlan Pharmaceutical is a China-based pharmaceutical company primarily engaged in the research, development, production, and sale of chemical drugs and Traditional Chinese Medicine (TCM). The company operates a large-scale manufacturing base in the Gansu province, focusing on essential medicines including antibiotics, cardiovascular treatments, and respiratory drugs. Its product portfolio encompasses various dosage forms such as tablets, capsules, and granules. Gansu Xinlan Pharmaceutical serves both domestic and regional markets, positioning itself as a key integrated supplier of generic pharmaceuticals and health products in Northwest China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Xinlan Pharmaceutical.